Pan-cancer analysis of the effect of biopsy site on tumor mutational burden observations
Plain language summary The total number of mutations, or changes, found within the DNA of cancer cells in a tumor sample is known as the tumor mutational burden (TMB). TMB scores have been proposed to be a marker of how well a tumor might respond to immunotherapy, a type of treatment that triggers t...
Saved in:
Main Authors: | Simon Papillon-Cavanagh, Julia F. Hopkins, Shakti H. Ramkissoon, Lee A. Albacker, Alice M. Walsh |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/4e897cbc9b7e4b24833e722c9700416e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden
by: Parikh AR, et al.
Published: (2018) -
Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds
by: Burair A. Alsaihati, et al.
Published: (2021) -
Panels and models for accurate prediction of tumor mutation burden in tumor samples
by: Elizabeth Martínez-Pérez, et al.
Published: (2021) -
Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups
by: Yan W. Asmann, et al.
Published: (2021) -
Expert Consensus on Tumor Mutational Burden for Immunotherapy in Lung Cancer
by: Chinese Society of Clinical Oncology, Expert Committee on Tumor Vascular-targeted Therapy, et al.
Published: (2021)